Alcohol does not impact chronic hepatitis C treatment outcomes but increases risk for progressive liver disease: Findings from a prospective multicentre Australian study (OPERA-C).
Paul J ClarkPatricia Casarolli ValerySimone I StrasserMartin WeltmanAlex ThompsonMiriam T LevyBarbara LeggettAmany ZekryJulian RongMarie SinclairJacob GeorgeWilliam SievertGerry MacQuillanEdmund TseAmanda NicollAmanda WadeWendy ChengStuart K RobertsPublished in: Drug and alcohol review (2024)
Risky alcohol use in HCV patients was prevalent, but did not reduce HCV cure. Treatment for alcohol dependence was low. Risky alcohol use may be under-recognised in liver clinics. Better integration of addiction medicine into liver services and increased resourcing and addiction medicine training opportunities for hepatologists may help address this.
Keyphrases
- hepatitis c virus
- primary care
- end stage renal disease
- ejection fraction
- healthcare
- multiple sclerosis
- clinical trial
- human immunodeficiency virus
- prognostic factors
- alcohol consumption
- mental health
- randomized controlled trial
- study protocol
- peritoneal dialysis
- cross sectional
- liver fibrosis
- double blind
- virtual reality
- combination therapy
- health insurance